Table 2.
Treatment approaches for early and advanced stage gastric cancer by participant surgeons.
| Approach | n (%), total n=112 |
|---|---|
| Early gastric cancer: c T1a N0 M0 | |
| Endoscopic resection | 94 (83.9) |
| Laparoscopic surgery | 11 (9.8) |
| Open surgery | 7 (6.3) |
| Locoregional disease: c T1b N0 M0 | |
| Endoscopic resection | 16 (14.3) |
| Laparoscopic surgery | 85 (75.9) |
| Open surgery | 11 (9.8) |
| Preoperative chemoradiation | 0 (0) |
| Perioperative chemotherapy | 0 (0) |
| Locoregional disease: c T2-T4a N0 M0 | |
| Laparoscopic surgery | 30 (26.8) |
| Open surgery | 76 (67.8) |
| Preoperative chemoradiation | 0 (0) |
| Perioperative chemotherapy | 6 (5.4) |
| Locoregional disease: c T4b N0 M0 | |
| Laparoscopic surgery | 7 (6.3) |
| Open surgery, En bloc resection | 96 (85.7) |
| Preoperative chemoradiation | 0 (0) |
| Perioperative chemotherapy | 9 (8.0) |
| Locoregional disease: c N+ M0 | |
| Laparoscopic surgery | 21 (18.8) |
| Open surgery | 79 (70.5) |
| Preoperative chemoradiation | 0 (0) |
| Perioperative chemotherapy | 12 (10.7) |